Skip to main content

Anaptysbio, Inc 10-Q for FY2026 Q3

Anaptysbio, Inc (ANAB)

10-Q 2026-05-12 For: 2026-03-31
View Original
Added on May 12, 2026

About this 10-Q

Anaptysbio, Inc filed this 10-Q on May 12, 2026, covering the quarter ended March 31, 2026 (FY2026 Q3).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$25.56M
down 8.0% from $27.77M a year earlier
Net loss
$52.88M
compared with a net loss of $39.33M a year earlier
Diluted EPS
-$1.84
compared with -$1.28 a year earlier